EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives

Pingxian Liu, Yunhan Jiang, Ling Jiao, Youfu Luo iD, Xiaodong Wang, Tao Yang iD

Journal of Medicinal Chemistry · 26.10.2023 · 66 (20) · 13860-13873

DOI: 10.1021/acs.jmedchem.3c01040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.10.2023. Verfasst von Pingxian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases and Laboratory of Human Diseases and Immunotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Oxazolidinones. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxazolidinones represent a significant class of synthetic bacterial protein synthesis inhibitors that are primarily effective against Gram-positive bacteria. The commercial success of linezolid, the first FDA-approved oxazolidinone antibiotic, has motivated researchers to develop more potent oxazolidinones by employing various drug development strategies to fight against antimicrobial resistance, some of which have shown promising results. Thus, this Perspective aims to discuss the strategies employed in constructing oxazolidinone-based antibacterial agents and summarize recent advances in discovering oxazolidinone antibiotics to provide valuable insights for potentially developing next-generation oxazolidinone antibacterial agents or other pharmaceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxazolidinonesAnti-Bacterial AgentsLinezolidProtein Synthesis InhibitorsGram-Positive BacteriaMicrobial Sensitivity Tests

Substanzen

OxazolidinonesAnti-Bacterial AgentsLinezolidProtein Synthesis Inhibitors

Autor:innen und Institutionen

  • Center of Infectious Diseases and Laboratory of Human Diseases and Immunotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
  • State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Youfu Luo, Tao Yang

Förderung

  • Department of Science and Technology of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, P., Jiang, Y., Jiao, L., Luo, Y., Wang, X., & Yang, T. (2023). Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives. Journal of Medicinal Chemistry, 66(20), 13860-13873. https://doi.org/10.1021/acs.jmedchem.3c01040

Vancouver

Liu P, Jiang Y, Jiao L, Luo Y, Wang X, Yang T. Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives. Journal of Medicinal Chemistry. 2023;66(20):13860-13873. doi:10.1021/acs.jmedchem.3c01040

BibTeX
@article{Liu2023,
  author = {Liu, Pingxian and Jiang, Yunhan and Jiao, Ling and Luo, Youfu and Wang, Xiaodong and Yang, Tao},
  title = {Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {20},
  pages = {13860--13873},
  doi = {10.1021/acs.jmedchem.3c01040}
}
Kostenlos starten →